Siemens Digitalization & Sustainable Solutions Ensure Labs are Safe, Secure and Compliant. Life Science Solutions from Siemens: Leading the Way in Science. Learn More Today!
- Scale up production
Smart life science technologies
can optimize your project timelines
- Security for your lab
Free Whitepaper Download
Protect Critical Environments
- Journey along a smart lab
Linking operational efficiency &
worker safety to stay ahead.
- Decarbonization
Learn how decarbonization will
shape the life sciences.
- Future proof your lab
Embrace big data to connect with
workers and optimize your lab.
- A green lab approach
A Green Lab balances temp, humidity
& lighting for occupants' safety.
- Scale up production
Suchergebnisse
Suchergebnisse:
Vor 11 Stunden · She has a postgraduate degree in International Journalism from City, University of London. An FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on ...
Vor 4 Stunden · This expects the weight loss drug market to sit at a whopping $130 billion by 2023 end, allowing Eli Lilly and Company (NYSE:LLY) to potentially double its current revenue even if it captured just ...
Vor 4 Stunden · Pinebridge Investments L.P. increased its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 19.2% in the 4th quarter, HoldingsChannel reports. The fund owned 131,427 shares of the company’s stock after acquiring an additional 21,157 shares during the period. Eli Lilly and Company accounts for approximately 0.7% of Pinebridge Investments L.P.’s holdings, making […]
Vor 4 Stunden · The two pharmaceutical companies are currently the only companies licensed to supply GLP-1 agonist drugs for weight loss under the brand names: Zepbound, which is Eli Lilly’s version, and Wegovy ...
Vor einem Tag · 2024-06-06 20:49. On Thursday, Eli Lilly and Company's (NYSE: LLY ) price target was raised to $957 from the previous $925 by Jefferies, while the firm maintained a Buy rating on the pharmaceutical company's shares. The adjustment follows a review of documents related to Eli Lilly's investigational Alzheimer's treatment, Donanemab, ahead of an ...
Vor 4 Stunden · Eli Lilly and Company is a global pharmaceutical company that discovers, develops, manufactures, and sells medicines in the categories of diabetes, oncology, neuroscience, and immunology, among other areas. Stock performance was strong due to robust fourth quarter sales of Mounjaro/ Zepbound, better-than-anticipated initial guidance for fiscal year 2024, and ongoing enthusiasm surrounding the ...
Vor einem Tag · In a recent transaction, Lilly Endowment Inc, a significant shareholder in Eli Lilly & Co (NYSE:LLY), has sold a considerable number of shares in the pharmaceutical company. The sales, which took place on June 5, 2024, involved a total of 20,383 shares of common stock, resulting in proceeds exceeding $17 million.
